Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Trimelamol analogue available for licensing from CRCT

May 12, 1999

Isis initiates phase II clinical trials of ISIS-2503

May 11, 1999

Non-cysteine-containing FTase inhibitors from Abbott with good oral bioavailability

May 11, 1999

Telomerase inhibitors available for licensing from CRCT

May 11, 1999

Antioxidant di- and triacetic acid derivatives: preparation and use described by L'Oreal

May 11, 1999

Structural Bioinformatics develops antagonists of BcL-2 gene product

May 10, 1999

Licensing opportunity from NIH: recombinant antitumor RNases

May 10, 1999

BE-55051: novel antitumor substance produced by Streptomyces

May 7, 1999

Second-generation SERM advances through the Lilly pipeline

May 7, 1999

Clinical trials of SuperGen's RFS-2000 expanded to Europe

May 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...